Your browser doesn't support javascript.
loading
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.
Gregucci, Fabiana; Spada, Sheila; Barcellos-Hoff, Mary Helen; Bhardwaj, Nina; Chan Wah Hak, Charleen; Fiorentino, Alba; Guha, Chandan; Guzman, Monica L; Harrington, Kevin; Herrera, Fernanda G; Honeychurch, Jamie; Hong, Theodore; Iturri, Lorea; Jaffee, Elisabeth; Karam, Sana D; Knott, Simon R V; Koumenis, Constantinos; Lyden, David; Marciscano, Ariel E; Melcher, Alan; Mondini, Michele; Mondino, Anna; Morris, Zachary S; Pitroda, Sean; Quezada, Sergio A; Santambrogio, Laura; Shiao, Stephen; Stagg, John; Telarovic, Irma; Timmerman, Robert; Vozenin, Marie-Catherine; Weichselbaum, Ralph; Welsh, James; Wilkins, Anna; Xu, Chris; Zappasodi, Roberta; Zou, Weiping; Bobard, Alexandre; Demaria, Sandra; Galluzzi, Lorenzo; Deutsch, Eric; Formenti, Silvia C.
Afiliação
  • Gregucci F; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Spada S; Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti, Bari, Italy.
  • Barcellos-Hoff MH; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Bhardwaj N; Department of Radiation Oncology, School of Medicine, University of California, San Francisco, CA, USA.
  • Chan Wah Hak C; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Fiorentino A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Guha C; Translational Immunotherapy Team, The Institute of Cancer Research, London, UK.
  • Guzman ML; Department of Radiation Oncology, Miulli General Regional Hospital, Acquaviva delle Fonti, Bari, Italy.
  • Harrington K; Department of Medicine and Surgery, LUM University, Casamassima, Bari, Italy.
  • Herrera FG; Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA.
  • Honeychurch J; Division of Hematology/Oncology, Department of Medicine, Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA.
  • Hong T; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Iturri L; The Institute of Cancer Research/The Royal Marsden NHS Foundation Trust, National Institute for Health Research Biomedical Research Centre, London, UK.
  • Jaffee E; Centre Hospitalier Universitaire Vaudois, University of Lausanne and Ludwig Institute for Cancer Research at the Agora Cancer Research Center, Lausanne, Switzerland.
  • Karam SD; Division of Cancer Sciences, University of Manchester, Manchester, UK.
  • Knott SRV; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Koumenis C; Institut Curie, Université PSL, CNRS UMR3347, INSERM U1021, Signalisation Radiobiologie et Cancer, Orsay, France.
  • Lyden D; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
  • Marciscano AE; Department of Radiation Oncology, University of Colorado, Aurora, CO, USA.
  • Melcher A; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Mondini M; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Mondino A; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Morris ZS; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Pitroda S; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK.
  • Quezada SA; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Santambrogio L; Université of Paris-Saclay, Saclay, France.
  • Shiao S; INSERM U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, Villejuif, France.
  • Stagg J; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Telarovic I; Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Timmerman R; Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, USA.
  • Vozenin MC; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
  • Weichselbaum R; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Welsh J; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Wilkins A; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA.
  • Xu C; Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Zappasodi R; Centre de Recherche du Centre Hospitalier de l'Universite de Montreal, Faculty of Pharmacy, Montreal, Canada.
  • Zou W; Laboratory for Applied Radiobiology, Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Bobard A; Departments of Radiation Oncology and Neurosurgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Demaria S; Laboratory of Radiation Oncology, Radiation Oncology Service, Department of Oncology, CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Galluzzi L; Department of Radiation and Cellular Oncology, Ludwig Center for Metastases Research, University of Chicago, IL, USA.
  • Deutsch E; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Formenti SC; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom, Royal Marsden Hospital, Sutton, UK.
Oncoimmunology ; 12(1): 2222560, 2023.
Article em En | MEDLINE | ID: mdl-37363104

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article